🫁

Pulmonary Function Tests Overview

Sep 4, 2025

Overview

This lecture covers Pulmonary Function Tests (PFTs), focusing on how to differentiate between obstructive and restrictive lung diseases using key measurements and algorithms.

Pulmonary Function Tests (PFTs) Basics

  • PFTs are a group of tests used to assess lung function and differentiate between obstructive and restrictive lung diseases.
  • The main tests include spirometry (measuring airflow), lung volume measurements, and diffusion capacity.
  • Flow volume loops and various lung volumes are essential in interpreting results.

Lung Volumes in Obstructive vs. Restrictive Disease

  • Obstructive diseases have increased residual volume (RV) and functional residual capacity (FRC) due to air trapping and hyperinflation.
  • Restrictive diseases show decreased RV and FRC because lungs are stiff and difficult to expand.
  • Total lung capacity (TLC) is increased in obstructive disease and decreased in restrictive disease.

Flow Volume Loops

  • Normal: Baseline for comparison.
  • Obstructive: Loop shifts left, TLC and RV increase, Forced Vital Capacity (FVC) decreases.
  • Restrictive: Loop shifts right, TLC and RV decrease, FVC is significantly reduced.

Spirometry: FEV1, FVC, and FEV1/FVC Ratio

  • FEV1 (forced expiratory volume in 1 second) is significantly reduced in obstruction; mildly reduced in restriction.
  • FVC is most reduced in restriction.
  • FEV1/FVC ratio <70% indicates obstruction; ≥70% suggests restriction or normal.

Bronchodilator and Bronchoconstrictor Testing

  • Administer a beta-2 agonist to distinguish asthma from COPD.
  • FEV1 increase >12% after bronchodilator suggests reversible (asthmatic) airway disease.
  • FEV1 drop ≥20% after bronchoconstrictor (methacholine) indicates inducible airway (asthma).
  • Lack of reversibility suggests COPD.

Diffusion Capacity (DLCO)

  • DLCO evaluates how well gases diffuse across the alveolar membrane.
  • Low DLCO in obstructive diseases suggests emphysema (due to alveolar destruction).
  • In restrictive diseases, low DLCO implies intrinsic disease (interstitial fibrosis), normal DLCO suggests extrinsic causes (e.g., chest wall issues).

Diagnostic Algorithm Summary

  • FEV1/FVC <70% + high lung volumes = obstructive; check for reversibility and DLCO for asthma vs. COPD.
  • FEV1/FVC ≥70% + low lung volumes = restrictive; DLCO distinguishes intrinsic (low DLCO) from extrinsic (normal DLCO) causes.
  • Use flow volume loop shifts (left = obstructive, right = restrictive) as visual support.

Key Terms & Definitions

  • PFT (Pulmonary Function Test) — group of tests evaluating lung function.
  • RV (Residual Volume) — air left after maximal exhalation.
  • FRC (Functional Residual Capacity) — RV + Expiratory Reserve Volume (ERV).
  • TLC (Total Lung Capacity) — total air in lungs after maximal inhalation.
  • FEV1 — forced expiratory volume in the first second.
  • FVC — forced vital capacity, total air exhaled forcefully after full inhalation.
  • FEV1/FVC Ratio — differentiates between obstructive and restrictive patterns.
  • DLCO — diffusion capacity for carbon monoxide, measures gas exchange efficiency.

Action Items / Next Steps

  • Review flow volume loops for obstructive and restrictive patterns.
  • Practice interpreting spirometry values (FEV1, FVC, FEV1/FVC).
  • Understand diagnostic steps for distinguishing asthma, COPD, and types of restrictive lung disease using PFTs.